Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes
Eli Lilly and Company
Julio Rosenstock; Stanley Hsia; Luis Nevarez Ruiz; Sarah Eyde; David Cox; Wen-Shuo Wu; Rong Liu; Jianghao Li; Laura Fernández Landó; Max Denning; Lisa Ludwig; Yanyun Chen; ACHIEVE-1 Trial Investigators